Haslett, MI, United States of America

Keyvan Nazerian

This inventor holds 4 USPTO granted patents. Top assignees: The United States of America as Represented by the Secretary of, Nippon Zeon Company, Ltd., Other. Active years: 1983-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keyvan Nazerian. Retrieved from https://idiyas.com/inventor/keyvan-nazerian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 46(Granted Patents)


Location History:

  • East Lansing, MI (US) (1983)
  • Haslett, MI (US) (1994 - 1995)
  • Skokie, IL (US) (2001)

Company Filing History:


Years Active: 1983-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Keyvan Nazerian: Innovator in Avian Vaccines

Introduction

Keyvan Nazerian is a notable inventor based in Haslett, MI (US). He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for poultry. With a total of 4 patents to his name, Nazerian's work has had a substantial impact on avian health.

Latest Patents

Nazerian's latest patents focus on Marek's disease virus vaccines designed to protect against Marek's disease. One of his key inventions includes a nucleotide sequence encoding the gp82 polypeptide of Marek's disease virus. This patent discloses recombinant viruses that serve as vaccines, preferably containing multiple genes encoding Marek's Disease Virus antigens, such as glycoprotein B and glycoprotein gp82. These genes are controlled by a poxvirus promoter within a non-essential region of the fowlpox virus DNA. Additionally, he has developed a vaccine that exhibits a synergistic immunoprotective effect, which combines a recombinant fowlpox virus expressing Marek's Disease Virus gB protein with turkey herpesvirus. Furthermore, he has created a vaccine comprising fowlpox virus recombinants that express the envelope glycoprotein of spleen necrosis virus, aimed at protecting against avian reticuloendotheliosis virus-associated diseases.

Career Highlights

Throughout his career, Keyvan Nazerian has worked with various organizations, including the United States of America as Represented by the Secretary of Agriculture and Nippon Zeon Company, Ltd. His innovative work has positioned him as a key figure in the development of avian vaccines.

Collaborations

Nazerian has collaborated with notable individuals in his field, including Noboru Yanagida and Richard L Witter. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Keyvan Nazerian's contributions to avian health through his innovative vaccine technologies demonstrate his commitment to improving poultry welfare. His work continues to influence the field of veterinary medicine and highlights the importance of research in combating avian diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…